Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy

Molecular Cell

Volumn 60, Issue 4, 2015, Pages 537-546

  Koren, Shany ^a   Bentires Alj, Mohamed ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST TUMOR; CANCER GENETICS; CANCER HETEROGENEITY; CANCER THERAPY; CELL DIFFERENTIATION; CELL HETEROGENEITY; GENETIC VARIABILITY; HUMAN; NONHUMAN; ONCOLOGICAL PARAMETERS; PLASTICITY; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; CANCER STEM CELL; CELL PLASTICITY; FEMALE; GENETIC HETEROGENEITY; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; BREAST NEOPLASMS; CELL PLASTICITY; FEMALE; GENETIC HETEROGENEITY; HUMANS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84947781605     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2015.10.031     Document Type: Review

References (124)

1. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
2. Banerji S., Cibulskis K., Rangel-Escareno C., Brown K.K., Carter S.L., Frederick A.M., Lawrence M.S., Sivachenko A.Y., Sougnez C., Zou L., et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 2012, 486:405-409.
3. Bhang H.E., Ruddy D.A., Krishnamurthy Radhakrishna V., Caushi J.X., Zhao R., Hims M.M., Singh A.P., Kao I., Rakiec D., Shaw P., et al. Studying clonal dynamics in response to cancer therapy using high-complexity barcoding. Nat. Med. 2015, 21:440-448.
4. Bissell M.J., Hines W.C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 2011, 17:320-329.
5. Bissell M.J., Rizki A., Mian I.S. Tissue architecture: the ultimate regulator of breast epithelial function. Curr. Opin. Cell Biol. 2003, 15:753-762.
6. Bousquet G., Feugeas J.P., Ferreira I., Vercellino L., Jourdan N., Bertheau P., de Bazelaire C., Barranger E., Janin A. Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma. Breast Cancer Res. 2014, 16:401.
7. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. Cancer Genome Atlas Network.
8. Cardiff R.D. Validity of mouse mammary tumour models for human breast cancer: comparative pathology. Microsc. Res. Tech. 2001, 52:224-230.
9. Cardiff R.D., Anver M.R., Gusterson B.A., Hennighausen L., Jensen R.A., Merino M.J., Rehm S., Russo J., Tavassoli F.A., Wakefield L.M., et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000, 19:968-988.
10. Cassidy J.W., Caldas C., Bruna A. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts. Cancer Res. 2015, 75:2963-2968.
11. Chaffer C.L., Brueckmann I., Scheel C., Kaestli A.J., Wiggins P.A., Rodrigues L.O., Brooks M., Reinhardt F., Su Y., Polyak K., et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. USA 2011, 108:7950-7955.
12. Chaffer C.L., Marjanovic N.D., Lee T., Bell G., Kleer C.G., Reinhardt F., D'Alessio A.C., Young R.A., Weinberg R.A. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013, 154:61-74.
13. Choi N., Zhang B., Zhang L., Ittmann M., Xin L. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 2012, 21:253-265.
14. Clark S.E., Warwick J., Carpenter R., Bowen R.L., Duffy S.W., Jones J.L. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br. J. Cancer 2011, 104:120-127.
15. Cleary A.S., Leonard T.L., Gestl S.A., Gunther E.J. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature 2014, 508:113-117.
16. Cohen J.C., Shank P.R., Morris V.L., Cardiff R., Varmus H.E. Integration of the DNA of mouse mammary tumor virus in virus-infected normal and neoplastic tissue of the mouse. Cell 1979, 16:333-345.
17. Curtis C., Shah S.P., Chin S.F., Turashvili G., Rueda O.M., Dunning M.J., Speed D., Lynch A.G., Samarajiwa S., Yuan Y., et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352. METABRIC Group.
18. D'Amato N.C., Ostrander J.H., Bowie M.L., Sistrunk C., Borowsky A., Cardiff R.D., Bell K., Young L.J., Simin K., Bachelder R.E., et al. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. PLoS ONE 2012, 7:e45684.
19. Darwin C. The Origin of Species 2010, CreateSpace Independent Publishing Platform.
20. De Palma M., Hanahan D. The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities. Mol. Oncol. 2012, 6:111-127.
21. de Visser K.E., Ciampricotti M., Michalak E.M., Tan D.W., Speksnijder E.N., Hau C.S., Clevers H., Barker N., Jonkers J. Developmental stage-specific contribution of LGR5(+) cells to basal and luminal epithelial lineages in the postnatal mammary gland. J. Pathol. 2012, 228:300-309.
22. Deome K.B., Faulkin L.J., Bern H.A., Blair P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 1959, 19:515-520.
23. DeRose Y.S., Wang G., Lin Y.C., Bernard P.S., Buys S.S., Ebbert M.T., Factor R., Matsen C., Milash B.A., Nelson E., et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat. Med. 2011, 17:1514-1520.
24. Desmedt C., Fumagalli D., Pietri E., Zoppoli G., Brown D., Nik-Zainal S., Gundem G., Rothé F., Majjaj S., Garuti A., et al. Uncovering the genomic heterogeneity of multifocal breast cancer. J. Pathol. 2015, 236:457-466.
25. Ding L., Ellis M.J., Li S., Larson D.E., Chen K., Wallis J.W., Harris C.C., McLellan M.D., Fulton R.S., Fulton L.L., et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010, 464:999-1005.
26. Dumont N., Liu B., Defilippis R.A., Chang H., Rabban J.T., Karnezis A.N., Tjoe J.A., Marx J., Parvin B., Tlsty T.D. Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics. Neoplasia 2013, 15:249-262.
27. Eirew P., Stingl J., Raouf A., Turashvili G., Aparicio S., Emerman J.T., Eaves C.J. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat. Med. 2008, 14:1384-1389.
28. Eirew P., Steif A., Khattra J., Ha G., Yap D., Farahani H., Gelmon K., Chia S., Mar C., Wan A., et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 2015, 518:422-426.
29. Ellis M.J., Ding L., Shen D., Luo J., Suman V.J., Wallis J.W., Van Tine B.A., Hoog J., Goiffon R.J., Goldstein T.C., et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012, 486:353-360.
30. Faulkin L.J., Deome K.B. Regulation of growth and spacing of gland elements in the mammary fat pad of the C3H mouse. J. Natl. Cancer Inst. 1960, 24:953-969.
31. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., Martinez P., Matthews N., Stewart A., Tarpey P., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 2012, 366:883-892.
32. Ghajar C.M., Peinado H., Mori H., Matei I.R., Evason K.J., Brazier H., Almeida D., Koller A., Hajjar K.A., Stainier D.Y., et al. The perivascular niche regulates breast tumour dormancy. Nat. Cell Biol. 2013, 15:807-817.
33. Goubran H.A., Kotb R.R., Stakiw J., Emara M.E., Burnouf T. Regulation of tumor growth and metastasis: the role of tumor microenvironment. Cancer Growth Metastasis 2014, 7:9-18.
34. Gudjonsson T., Villadsen R., Nielsen H.L., Rønnov-Jessen L., Bissell M.J., Petersen O.W. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 2002, 16:693-706.
35. Gunther E.J., Belka G.K., Wertheim G.B., Wang J., Hartman J.L., Boxer R.B., Chodosh L.A. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 2002, 16:283-292.
36. Guo W., Keckesova Z., Donaher J.L., Shibue T., Tischler V., Reinhardt F., Itzkovitz S., Noske A., Zürrer-Härdi U., Bell G., et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 2012, 148:1015-1028.
37. Gupta P.B., Fillmore C.M., Jiang G., Shapira S.D., Tao K., Kuperwasser C., Lander E.S. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011, 146:633-644.
38. Gusterson B. Do 'basal-like' breast cancers really exist?. Nat. Rev. Cancer 2009, 9:128-134.
39. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 1992, 12:954-961.
40. Hector A., Hooper R. Ecology. Darwin and the first ecological experiment. Science 2002, 295:639-640.
41. Hennighausen L., Robinson G.W. Signaling pathways in mammary gland development. Dev. Cell 2001, 1:467-475.
42. Herschkowitz J.I., Simin K., Weigman V.J., Mikaelian I., Usary J., Hu Z., Rasmussen K.E., Jones L.P., Assefnia S., Chandrasekharan S., et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 2007, 8:R76.
43. Hidalgo M., Amant F., Biankin A.V., Budinská E., Byrne A.T., Caldas C., Clarke R.B., de Jong S., Jonkers J., Mælandsmo G.M., et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014, 4:998-1013.
44. Hollern D.P., Andrechek E.R. A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer. Breast Cancer Res. 2014, 16:R59.
45. Ince T.A., Richardson A.L., Bell G.W., Saitoh M., Godar S., Karnoub A.E., Iglehart J.D., Weinberg R.A. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 2007, 12:160-170.
46. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
47. Jiang Z., Deng T., Jones R., Li H., Herschkowitz J.I., Liu J.C., Weigman V.J., Tsao M.S., Lane T.F., Perou C.M., Zacksenhaus E. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J. Clin. Invest. 2010, 120:3296-3309.
48. Jonkers J., Meuwissen R., van der Gulden H., Peterse H., van der Valk M., Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 2001, 29:418-425.
49. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
50. Keller P.J., Arendt L.M., Skibinski A., Logvinenko T., Klebba I., Dong S., Smith A.E., Prat A., Perou C.M., Gilmore H., et al. Defining the cellular precursors to human breast cancer. Proc. Natl. Acad. Sci. USA 2012, 109:2772-2777.
51. Kendrick H., Regan J.L., Magnay F.A., Grigoriadis A., Mitsopoulos C., Zvelebil M., Smalley M.J. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 2008, 9:591.
52. Klevebring D., Rosin G., Ma R., Lindberg J., Czene K., Kere J., Fredriksson I., Bergh J., Hartman J. Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo. Breast Cancer Res. 2014, 16:R72.
53. Komaki K., Sano N., Tangoku A. Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer. Breast Cancer 2006, 13:249-253.
54. Kordon E.C., Smith G.H. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998, 125:1921-1930.
55. Koren S., Bentires-Alj M. Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors. FEBS J. 2013, 280:2758-2765.
56. Koren S., Reavie L., Couto J.P., De Silva D., Stadler M.B., Roloff T., Britschgi A., Eichlisberger T., Kohler H., Aina O., et al. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature 2015, 525:114-118.
57. Kreso A., Dick J.E. Evolution of the cancer stem cell model. Cell Stem Cell 2014, 14:275-291.
58. Kuperwasser C., Chavarria T., Wu M., Magrane G., Gray J.W., Carey L., Richardson A., Weinberg R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. USA 2004, 101:4966-4971.
59. Lim E., Vaillant F., Wu D., Forrest N.C., Pal B., Hart A.H., Asselin-Labat M.L., Gyorki D.E., Ward T., Partanen A., et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009, 15:907-913. kConFab.
60. Lim E., Wu D., Pal B., Bouras T., Asselin-Labat M.L., Vaillant F., Yagita H., Lindeman G.J., Smyth G.K., Visvader J.E. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 2010, 12:R21.
61. Lin S.C., Lee K.F., Nikitin A.Y., Hilsenbeck S.G., Cardiff R.D., Li A., Kang K.W., Frank S.A., Lee W.H., Lee E.Y. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res. 2004, 64:3525-3532.
62. Linnemann J.R., Miura H., Meixner L.K., Irmler M., Kloos U.J., Hirschi B., Bartsch H.S., Sass S., Beckers J., Theis F.J., et al. Quantification of regenerative potential in primary human mammary epithelial cells. Development 2015, 142:3239-3251.
63. Liu X., Holstege H., van der Gulden H., Treur-Mulder M., Zevenhoven J., Velds A., Kerkhoven R.M., van Vliet M.H., Wessels L.F., Peterse J.L., et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc. Natl. Acad. Sci. USA 2007, 104:12111-12116.
64. Macias H., Hinck L. Mammary gland development. Wiley Interdiscip. Rev. Dev. Biol. 2012, 1:533-557.
65. Marusyk A., Polyak K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta 2010, 1805:105-117.
66. Marusyk A., Almendro V., Polyak K. Intra-tumour heterogeneity: a looking glass for cancer?. Nat. Rev. Cancer 2012, 12:323-334.
67. Marusyk A., Tabassum D.P., Altrock P.M., Almendro V., Michor F., Polyak K. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 2014, 514:54-58.
68. Melchor L., Molyneux G., Mackay A., Magnay F.A., Atienza M., Kendrick H., Nava-Rodrigues D., López-García M.A., Milanezi F., Greenow K., et al. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models. J. Pathol. 2014, 233:124-137.
69. Meyer D.S., Brinkhaus H., Müller U., Müller M., Cardiff R.D., Bentires-Alj M. Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Res. 2011, 71:4344-4351.
70. Meyer D.S., Koren S., Leroy C., Brinkhaus H., Müller U., Klebba I., Müller M., Cardiff R.D., Bentires-Alj M. Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R. Oncogenesis 2013, 2:e74.
71. Molyneux G., Geyer F.C., Magnay F.A., McCarthy A., Kendrick H., Natrajan R., Mackay A., Grigoriadis A., Tutt A., Ashworth A., et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010, 7:403-417.
72. Muller W.J., Sinn E., Pattengale P.K., Wallace R., Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988, 54:105-115.
73. Nardella C., Lunardi A., Patnaik A., Cantley L.C., Pandolfi P.P. The APL paradigm and the "co-clinical trial" project. Cancer Discov. 2011, 1:108-116.
74. Navin N., Kendall J., Troge J., Andrews P., Rodgers L., McIndoo J., Cook K., Stepansky A., Levy D., Esposito D., et al. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94.
75. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.P., Tong F., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527.
76. Nguyen L.V., Makarem M., Carles A., Moksa M., Kannan N., Pandoh P., Eirew P., Osako T., Kardel M., Cheung A.M., et al. Clonal analysis via barcoding reveals diverse growth and differentiation of transplanted mouse and human mammary stem cells. Cell Stem Cell 2014, 14:253-263.
77. Nik-Zainal S., Alexandrov L.B., Wedge D.C., Van Loo P., Greenman C.D., Raine K., Jones D., Hinton J., Marshall J., Stebbings L.A., et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993. Breast Cancer Working Group of the International Cancer Genome Consortium.
78. Nik-Zainal S., Van Loo P., Wedge D.C., Alexandrov L.B., Greenman C.D., Lau K.W., Raine K., Jones D., Marshall J., Ramakrishna M., et al. The life history of 21 breast cancers. Cell 2012, 149:994-1007. Breast Cancer Working Group of the International Cancer Genome Consortium.
79. Nowell P.C. The clonal evolution of tumor cell populations. Science 1976, 194:23-28.
80. Pal B., Bouras T., Shi W., Vaillant F., Sheridan J.M., Fu N., Breslin K., Jiang K., Ritchie M.E., Young M., et al. Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2. Cell Rep. 2013, 3:411-426.
81. Perou C.M., Sørlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
82. Petersen O.W., Polyak K. Stem cells in the human breast. Cold Spring Harb. Perspect. Biol. 2010, 2:a003160.
83. Pfefferle A.D., Herschkowitz J.I., Usary J., Harrell J.C., Spike B.T., Adams J.R., Torres-Arzayus M.I., Brown M., Egan S.E., Wahl G.M., et al. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biol. 2013, 14:R125.
84. Phillips S., Prat A., Sedic M., Proia T., Wronski A., Mazumdar S., Skibinski A., Shirley S.H., Perou C.M., Gill G., et al. Cell-state transitions regulated by SLUG are critical for tissue regeneration and tumor initiation. Stem Cell Reports 2014, 2:633-647.
85. Prat A., Parker J.S., Karginova O., Fan C., Livasy C., Herschkowitz J.I., He X., Perou C.M. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010, 12:R68.
86. Prater M.D., Petit V., Alasdair Russell I., Giraddi R.R., Shehata M., Menon S., Schulte R., Kalajzic I., Rath N., Olson M.F., et al. Mammary stem cells have myoepithelial cell properties. Nature Cell Biol. 2014, 16:942-950.
87. Proia D.A., Kuperwasser C. Reconstruction of human mammary tissues in a mouse model. Nat. Protoc. 2006, 1:206-214.
88. Quail D.F., Joyce J.A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 2013, 19:1423-1437.
89. Ramos P., Bentires-Alj M. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance. Oncogene 2015, 34:3617-3626.
90. Reyal F., Guyader C., Decraene C., Lucchesi C., Auger N., Assayag F., De Plater L., Gentien D., Poupon M.F., Cottu P., et al. Molecular profiling of patient-derived breast cancer xenografts. Breast Cancer Res. 2012, 14:R11.
91. Rios A.C., Fu N.Y., Lindeman G.J., Visvader J.E. In situ identification of bipotent stem cells in the mammary gland. Nature 2014, 506:322-327.
92. Santagata S., Thakkar A., Ergonul A., Wang B., Woo T., Hu R., Harrell J.C., McNamara G., Schwede M., Culhane A.C., et al. Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J. Clin. Invest. 2014, 124:859-870.
93. Schwitalla S., Fingerle A.A., Cammareri P., Nebelsiek T., Göktuna S.I., Ziegler P.K., Canli O., Heijmans J., Huels D.J., Moreaux G., et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013, 152:25-38.
94. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
95. Shah S.P., Morin R.D., Khattra J., Prentice L., Pugh T., Burleigh A., Delaney A., Gelmon K., Guliany R., Senz J., et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813.
96. Shah S.P., Roth A., Goya R., Oloumi A., Ha G., Zhao Y., Turashvili G., Ding J., Tse K., Haffari G., et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486:395-399.
97. Sinn E., Muller W., Pattengale P., Tepler I., Wallace R., Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 1987, 49:465-475.
98. Skibinski A., Kuperwasser C. The origin of breast tumor heterogeneity. Oncogene 2015, 34:5309-5316.
99. Sleeman K.E., Kendrick H., Ashworth A., Isacke C.M., Smalley M.J. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res. 2006, 8:R7.
100. Sleeman K.E., Kendrick H., Robertson D., Isacke C.M., Ashworth A., Smalley M.J. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J. Cell Biol. 2007, 176:19-26.
101. Sørlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 2001, 98:10869-10874.
102. Sorlie T., Tibshirani R., Parker J., Hastie T., Marron J.S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 2003, 100:8418-8423.
103. Spike B.T., Engle D.D., Lin J.C., Cheung S.K., La J., Wahl G.M. A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell 2012, 10:183-197.
104. Stephens P.J., Tarpey P.S., Davies H., Van Loo P., Greenman C., Wedge D.C., Nik-Zainal S., Martin S., Varela I., Bignell G.R., et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012, 486:400-404. Oslo Breast Cancer Consortium (OSBREAC).
105. Sternlicht M.D. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res. 2006, 8:201.
106. Stewart T.A., Pattengale P.K., Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984, 38:627-637.
107. Stingl J., Eaves C.J., Zandieh I., Emerman J.T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 2001, 67:93-109.
108. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
109. Tabassum D.P., Polyak K. Tumorigenesis: it takes a village. Nat. Rev. Cancer 2015, 15:473-483.
110. Tao L., van Bragt M.P., Laudadio E., Li Z. Lineage tracing of mammary epithelial cells using cell-type-specific cre-expressing adenoviruses. Stem Cell Reports 2014, 2:770-779.
111. Tao L., van Bragt M.P., Li Z. A Long-Lived Luminal Subpopulation Enriched with Alveolar Progenitors Serves as Cellular Origin of Heterogeneous Mammary Tumors. Stem Cell Reports 2015, 5:60-74.
112. Troester M.A., Hoadley K.A., Sørlie T., Herbert B.S., Børresen-Dale A.L., Lønning P.E., Shay J.W., Kaufmann W.K., Perou C.M. Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res. 2004, 64:4218-4226.
113. van Amerongen R., Bowman A.N., Nusse R. Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 2012, 11:387-400.
114. Van Keymeulen A., Rocha A.S., Ousset M., Beck B., Bouvencourt G., Rock J., Sharma N., Dekoninck S., Blanpain C. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-193.
115. Van Keymeulen A., Lee M.Y., Ousset M., Brohée S., Rorive S., Giraddi R.R., Wuidart A., Bouvencourt G., Dubois C., Salmon I., et al. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity. Nature 2015, 525:119-123.
116. Viale G. The current state of breast cancer classification. Ann. Oncol. 2012, 23:x207-x210.
117. Villadsen R., Fridriksdottir A.J., Rønnov-Jessen L., Gudjonsson T., Rank F., LaBarge M.A., Bissell M.J., Petersen O.W. Evidence for a stem cell hierarchy in the adult human breast. J. Cell Biol. 2007, 177:87-101.
118. Visvader J.E., Stingl J. Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev. 2014, 28:1143-1158.
119. Voskoglou-Nomikos T., Pater J.L., Seymour L. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin. Cancer Res. 2003, 9:4227-4239.
120. Wang Z.A., Mitrofanova A., Bergren S.K., Abate-Shen C., Cardiff R.D., Califano A., Shen M.M. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat. Cell Biol. 2013, 15:274-283.
121. Whittle J.R., Lewis M.T., Lindeman G.J., Visvader J.E. Patient-derived xenograft models of breast cancer and their predictive power. Breast Cancer Res. 2015, 17:17.
122. Yates L.R., Gerstung M., Knappskog S., Desmedt C., Gundem G., Van Loo P., Aas T., Alexandrov L.B., Larsimont D., Davies H., et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 2015, 21:751-759.
123. Zardavas D., Baselga J., Piccart M. Emerging targeted agents in metastatic breast cancer. Nat. Rev. Clin. Oncol. 2013, 10:191-210.
124. Zhang X., Claerhout S., Prat A., Dobrolecki L.E., Petrovic I., Lai Q., Landis M.D., Wiechmann L., Schiff R., Giuliano M., et al. A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models. Cancer Res. 2013, 73:4885-4897.